NIH and Novartis End Late-Stage Hydroxychloroquine Trials By Sam | June 22, 2020 Faced with mounting evidence that hydroxychloroquine is ineffective in treating COVID-19, three trials of the drug have been terminated. Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter